Clinical trial
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
NCT00025610
Study timeline
Study start (unknown)1999-07-01Date precision: month
Registry last updated2013-09-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neuroblastomaunresolved
Interventions
carboplatinDRUG · verified · RxNorm: carboplatin
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
etoposideDRUG · verified · RxNorm: etoposide
vincristine sulfateDRUG · verified · RxNorm: vincristine sulfate
Sponsors & collaborators
European Infant Neuroblastoma Study Group - 1999lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00025610 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.